Generation of enhanced stability factor VIII variants by replacement of charged residues at the A2 domain interface
- PMID: 18650448
- PMCID: PMC2556611
- DOI: 10.1182/blood-2008-02-142158
Generation of enhanced stability factor VIII variants by replacement of charged residues at the A2 domain interface
Abstract
Factor VIII consists of a heavy chain (A1A2B domains) and light chain (A3C1C2 domains), whereas the contiguous A1A2 domains are separate subunits in the cofactor, factor VIIIa. The intrinsic instability of the cofactor results from weak affinity interactions of the A2 subunit within factor VIIIa. The charged residues Glu272, Asp519, Glu665, and Glu1984 appear buried at the interface of the A2 domain with either the A1 or A3 domain, and thus may impact protein stability. To determine the effects of these residues on procofactor/cofactor stability, these residues were individually replaced with either Ala or Val, and stable BHK cell lines expressing the B-domainless proteins were prepared. Specific activity and thrombin generation parameters for 7 of the 8 variants were more than 80% the wild-type value. Factor VIII activity at 52 degrees C to 60 degrees C and the decay of factor VIIIa activity after thrombin activation were monitored. Six of the 7 variants showing wild-type-like activity demonstrated enhanced stability, with the Glu1984Val variant showing a 2-fold increase in thermostability and an approximately 4- to 8-fold increase in stability of factor VIIIa. These results indicate that replacement of buried charged residues is an effective alternative to covalent modification in increasing factor VIII (VIIIa) stability.
Figures













Similar articles
-
Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa.J Biol Chem. 2008 Apr 25;283(17):11645-51. doi: 10.1074/jbc.M710252200. Epub 2008 Feb 25. J Biol Chem. 2008. PMID: 18299331 Free PMC article.
-
Modification of interdomain interfaces within the A3C1C2 subunit of factor VIII affects its stability and activity.Biochemistry. 2013 Jun 4;52(22):3921-9. doi: 10.1021/bi400295x. Epub 2013 May 21. Biochemistry. 2013. PMID: 23659383 Free PMC article.
-
Cofactor activity in factor VIIIa of the blood clotting pathway is stabilized by an interdomain bond between His281 and Ser524 formed in factor VIII.J Biol Chem. 2014 May 16;289(20):14020-9. doi: 10.1074/jbc.M114.550566. Epub 2014 Apr 1. J Biol Chem. 2014. PMID: 24692542 Free PMC article.
-
Factor VIII structure and function.Int J Hematol. 2006 Feb;83(2):103-8. doi: 10.1532/IJH97.05113. Int J Hematol. 2006. PMID: 16513527 Review.
-
Activation of factor VIII and mechanisms of cofactor action.Blood Rev. 2004 Mar;18(1):1-15. doi: 10.1016/s0268-960x(03)00025-0. Blood Rev. 2004. PMID: 14684146 Review.
Cited by
-
Factor VIII lacking the C2 domain retains cofactor activity in vitro.J Biol Chem. 2010 Aug 13;285(33):25176-84. doi: 10.1074/jbc.M110.106906. Epub 2010 Jun 7. J Biol Chem. 2010. PMID: 20529839 Free PMC article.
-
Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII.BMC Biotechnol. 2011 Nov 24;11:114. doi: 10.1186/1472-6750-11-114. BMC Biotechnol. 2011. PMID: 22115125 Free PMC article.
-
Role of hydrophobic mutations on the binding affinity and stability of blood coagulation factor VIIIa: a computational molecular dynamics and free-energy analysis.Biochem Biophys Res Commun. 2014 Jul 18;450(1):735-40. doi: 10.1016/j.bbrc.2014.06.043. Epub 2014 Jun 18. Biochem Biophys Res Commun. 2014. PMID: 24952158 Free PMC article.
-
Sequences flanking Arg336 in factor VIIIa modulate factor Xa-catalyzed cleavage rates at this site and cofactor function.J Biol Chem. 2012 May 4;287(19):15409-17. doi: 10.1074/jbc.M111.333948. Epub 2012 Mar 12. J Biol Chem. 2012. PMID: 22411993 Free PMC article.
-
Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy.Mol Ther Methods Clin Dev. 2018 Dec 31;12:184-201. doi: 10.1016/j.omtm.2018.12.007. eCollection 2019 Mar 15. Mol Ther Methods Clin Dev. 2018. PMID: 30705923 Free PMC article. Review.
References
-
- Fay PJ. Activation of factor VIII and mechanisms of cofactor action. Blood Rev. 2004;18:1–15. - PubMed
-
- Fay PJ. Reconstitution of human factor VIII from isolated subunits. Arch Biochem Biophys. 1988;262:525–531. - PubMed
-
- Ansong C, Miles SM, Fay PJ. Factor VIII A1 domain residues 97-105 represent a light chain-interactive site. Biochemistry. 2006;45:13140–13149. - PubMed
-
- Kaufman RJ, Pipe SW. Regulation of factor VIII expression and activity by von Willebrand factor. Thromb Haemost. 1999;82:201–208. - PubMed
-
- Wakabayashi H, Koszelak ME, Mastri M, Fay PJ. Metal ion-independent association of factor VIII subunits and the roles of calcium and copper ions for cofactor activity and inter-subunit affinity. Biochemistry. 2001;40:10293–10300. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources